🧬 New Technology added at Pharmidex in house now: Enhancing Precision in Coagulation Testing🧬
June 9, 2025

We're excited to announce the integration of the Sysmex CA-660 semi-automated Coagulation Analyzer into our lab infrastructure.


This compact yet powerful instrument brings clinical-grade coagulation testing to our preclinical workflows, enabling:


✅ High-precision clotting, chromogenic & immunoassays

✅ Low sample & reagent volume needs ideal for preclinical models

✅ Robust data reproducibility for decision-critical insights

✅ Easy-to-use interface for rapid turnaround


With the CA-660, Pharmidex is further enhancing its capacity to deliver accurate, consistent and fast coagulation studies, a key component in safety pharmacology, clinical pathology and drug development.


This system supports our mission to provide high-quality bioanalytical, DMPK and toxicology services to our partners in biotech and pharma.

Sysmex CA-660 semi-automated Coagulation Analyzer

#Pharmidex #Sysmex #CoagulationTesting #DrugDevelopment #PreclinicalResearch #Bioanalysis #DMPK #LifeSciences #InnovationInBiotech

BATA Taste Aversion

Does your compound taste good enough for the clinic?

July 24, 2025
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.

🔬 Now at Pharmidex: The 8HUM Model

July 21, 2025
Pharmidex is proud to offer access to the 8HUM model genetically humanized for 33 liver CYP enzymes responsible for metabolizing 90% of human drugs. ✅ Human-relevant metabolism data ✅ Supports IND-enabling ®gulatory studies ✅ Ideal for metabolite profiling, DDI risk & toxicity assessment By integrating 8HUM into our DMPK and in vivo studies, we deliver deeper, more predictive insights for safer, smarter drug development. 📩 Contact us to see how 8HUM can support your project.

🚨 We’re Hiring – Join the Pharmidex Team!

July 17, 2025
We’re growing and looking for passionate scientists to join our dynamic team. If you're excited by impactful science and meaningful collaboration, check out our latest roles: 🔬 Bioanalytical Scientist (Permanent) Work with LC-MS/MS platforms to support preclinical and clinical bioanalysis across a wide range of therapeutic areas. 🧫 Histology Technician (3-Month FTC, Full or Part-Time) Be at the heart of tissue processing for in vivo and toxicology studies GLP experience welcome, flexibility offered. 🧪 Scientist / Senior Scientist – Immunology (Full-Time) Advance autoimmune disease research through innovative T-cell and cytokine profiling assays. 💡 Why Pharmidex? ✔ 20+ years of scientific excellence ✔ Collaborative, science-led culture ✔ Diverse therapeutic expertise ✔ Real-world impact through discovery and development 📩 Ready to apply or want to learn more? Visit www.pharmidex.com/careers or email your CV to [email protected] Applications are reviewed on a rolling basis, early interest encouraged!  Let’s shape the future of drug discovery together.
More Posts